1-cyclopropyl-8-(difluoromethoxy)-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid methanesulfonate monohydrate,
T 3811ME,
T-3811ME,
Garenoxacin mesylate hydrate,
223652-90-2,
Garenoxacin mesylate,
Garenoxacin mesilate,
Garenoxacin (Mesylate hydrate),
UNII-OXI6EF55FR,
T-3811ME,
OXI6EF55FR,
Garenoxacin mesylate [USAN],
BMS-284756-01,
DSSTox_CID_28570,
DSSTox_RID_82842,
DSSTox_GSID_48644,
Garenoxacin mesylate (USAN),
(R)-1-cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid compound with methanesulfonic acid (1:1) hydrate,
Geninax,
1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid methanesulfonate hydrate,
CAS-223652-90-2,
BMS-284756,
NCGC00181770-01,
Inforce,
PubChem22428,
AC1L4IHT,
SCHEMBL2898521,
CHEMBL3183451,
DTXSID4048644,
IGTHEWGRXUAFKF-NVJADKKVSA-N,
Garenoxacin mesilate hydrate (JAN),
BCP08676,
Tox21_112995,
HY-17460A,
MFCD12031996,
Tox21_112995_1,
API0013697,
CS-4990,
NCGC00181770-02,
ACM223652902,
AN-15819,
AX8326791,
FT-0774053,
A25164,
D02540,
Garenoxacin mesylate monohydrate, >=98% (HPLC),
(R)-1-cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid compound with methanesulfoni,
(R)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinoline-carboxylic acid methanesulfonate monohydrate,
(R)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid methanesulfonate monohydrate,
1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid; methanesulfonic acid; hydrate,
1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methylisoindolin-5-yl]-4-oxo-quinoline-3-carboxylic acid; methanesulfonic acid; hydrate,
3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-((1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl)-1,4-dihydro-4-oxo-, monomethanesulfonate, monohydrate,
3-Quinolinecarboxylic acid,1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-, monomethanesulfonate, monohydrate,
Garenoxacin,
Garenoxacin mesylate monohydrate,
CID157690,
C23H20F2N2O4.CH4O3S.H2O,
T-3811,
C23-H20-F2-N2-O4.C-H4-O3-S.H2-O,
1-Cyclopropyl-8-(difluoromethoxy)-7-((1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monomethanesulfonate monohydrate,